share_log

上海市方达律师事务所关于无锡药明康德新药开发股份有限公司2022年年度股东大会、2023年第一次A股类别股东会议及2023年第一次H股类别股东会议的法律意见书

Legal opinions of Shanghai Fangda Law Firm on the 2022 Annual General Meeting of Shareholders of Wuxi Yaoming Kangde Pharmaceutical Development Co., Ltd., the first A-share shareholders\' meeting in 2023, and the first H-share shareholders\' meeting in 202

深证信a股 ·  May 31, 2023 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more